반응형
Global Data Intelligence Center | ||
구분 | 보고서 (영문) | 업로드 날짜 |
제약/바이오/임상시험 | Positive Results from Rybrevant Trial Solidify Janssen’s Foothold in EGFR-Mutated NSCLC | 09-08-2023 |
CureVac Highlights Shift in Seasonal Influenza Vaccines Development Pipeline | 09-14-2023 | |
Novo Nordisk’s Wegovy to Start Being Supplied by NHS in England | 09-15-2023 | |
Market Cap Rebound by Top 20 Biopharmaceutical Companies in Q2 2023 | 09-15-2023 | |
Forxiga Flunks Primary Endpoint in DICTATE-AHF Trial | 09-21-2023 | |
Alvotech’s AVT05 in Phase III Rheumatoid Arthritis Study, as the Sole Candidate | 09-21-2023 | |
GSK’s Ojjaara Receives FDA Approval for Treating Myelofibrosis Patients with Anemia | 09-21-2023 | |
Clinical Trials Feasibility, Risk Assessment and Planning for Success – A Case Study | 09-22-2023 | |
질환별 | Influence of Social Class on AIDS Incidence and Mortality in Brazil | 09-12-2023 |
Heart Failure: Epidemiology Forecast to 2032 | 09-19-2023 | |
Sepsis: 68-Market Analysis and Sales Forecast | 09-21-2023 | |
Can Steatosis-Associated Fibrosis Estimator Scores Improve Diagnosis of Nonalcoholic Fatty Liver Disease? | 09-21-2023 | |
New Evidence Shows Depression as a Major Risk for Type 2 Diabetes | 09-22-2023 | |
High Global Prevalence of HPV in Sexually Active Men | 09-22-2023 | |
The Burden of Hepatitis B and Hepatitis C-Related Illnesses | 09-22-2023 | |
컨퍼런스/심포지엄/학회 | Disparity in the Distance Between Disease Prevalent Populations and Trial Locations | 09-14-2023 |
Could Gilead's Trodelvy Be the Next TROP-2 Therapy Game-Changer in NSCLC Treatment | 09-22-2023 |
반응형
'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글
[국가임상시험지원재단] 해외 임상시험 정보데이터 (Global Data) 발간 보고서 제공 (0) | 2023.10.06 |
---|---|
[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 09.15(금) (0) | 2023.10.06 |
[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 09.04(월) (0) | 2023.09.05 |
[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 08.18(금) (0) | 2023.08.18 |
[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 08.04(금) (0) | 2023.08.18 |